Results 11 to 20 of about 1,468,261 (263)
The Health Costs of Cost-Sharing [PDF]
SSRN Electronic Journal, 2021 Abstract What happens when patients suddenly stop their medications? We study the health consequences of drug interruptions caused by large, abrupt, and arbitrary changes in price. Medicare’s prescription drug benefit as-if-randomly assigns 65-year-olds a drug budget as a function of their birth month, beyond which out-of-pocket costs ...
Amitabh, Chandra +2 more
openaire +2 more sources
Cost, Effectiveness, and Cost-Effectiveness [PDF]
Circulation: Cardiovascular Quality and Outcomes, 2009 Pluck the goose so as to obtain the most feathers with the least hissing . — —Jean-Baptiste Colbert, Minister of Finance to King Louis XIV of France Incremental or marginal cost-effectiveness ratios are founded on a number of assumptions that weaken their suitability as a way to balance competing economic and clinical priorities. We therefore propose
George A, Diamond, Sanjay, Kaul
openaire +2 more sources
Biomarkers of Inflammation in Obesity-Psoriatic Patients
Mediators of Inflammation, 2019 Psoriasis is a common chronic inflammatory multisystemic disease with a complex pathogenesis consisting of genetic, immunological, and environmental components.
Carmen Rodríguez-Cerdeira +8 more
doaj +1 more source
22nd Annual IEEE Symposium on Logic in Computer Science (LICS 2007), 2007 In an influential paper titled "The Benefits of Relaxing Punctuality", Alur, Feder, and~Henzinger introduced Metric Interval Temporal Logic~(MITL) as a fragment of the real-time logic Metric Temporal Logic~(MTL) in which exact or punctual timing constraints are banned.
Patricia Bouyer +3 more
openaire +3 more sources
¿CONVIENE TRASLADAR A PRECIOS LA REDUCCIÓN DE COSTOS VARIABLES PARA APROVECHAR CAPACIDAD OCIOSA?
Costos y Gestión, 2021 El artículo estudia los casos de empresas poliproductoras con restrictores comunes que estuvieren operando en óptimos de mercado con desaprovechamiento de capacidad productiva y/o comercial, focalizándose en proyectos de optimización de costos variables
Daniel Farré, Laura Ghezzi
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Sickle cell disease (SCD) is a chronic, inherited hemoglobinopathy that requires frequent hospitalization for disease‐related complications. Canadian data on inpatient care is limited. This study compared caregiver‐reported hospital experiences of children with SCD to those with cystic fibrosis (CF), a chronic, autosomal recessive ...
Hailey M. Zwicker +11 more
wiley +1 more source
Cost-parity and cost-Streett games [PDF]
FST&TCS, 2012 We consider two-player games played on finite graphs equipped with costs on edges and introduce two winning conditions, cost-parity and cost-Streett, which require bounds on the cost between requests and their responses. Both conditions generalize the corresponding classical ω-regular conditions as well as the corresponding finitary conditions.
Nathanaël Fijalkow +1 more
openaire +4 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook +6 more
wiley +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Neuromyelitis optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system. High‐dose intravenous methylprednisolone (IVMP) is the standard first‐line therapy for acute attacks, although some patients remain refractory.
Wataru Horiguchi +5 more
wiley +1 more source